Form D · Other Health Care
Techcyte, Inc.
Orem, UT · CIK 0001880286
Offering snapshot reported Jan 11, 2024 · SEC filing
- Reported sold
- $8.4M Offering amount: $8.4M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 22, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 11, 2024 | Initial | $8,400,000 | No comparison | 1 | SEC filing |
| Aug 26, 2021 | Initial | $20,930,675 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-502116
Source: Form D, filed Jan 11, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Aicher | Director |
| Ben Cahoon | Director, Executive |
| William Dorsey | Director |
| Kent Gordon | Director |
| Mohammed Salama | Director |
| Richard Smith | Director, Executive |
| Jay Tolley | Director |
| Kyle Wilson | Director |
| Michael Wolfgramm | Director |
| Ralph Yarro | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1106 North 1200 West
Orem, UT, 84057
Orem, UT, 84057